Skip to main content

Table 1 Patient characteristics at primary diagnosis and prior treatment

From: Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer

Parameters

No. of patients

Proportion of patients (%)

Age at primary diagnosis

 Median(y)

45

 Range(y)

31–67

 ≤50 y

36

70.6

 >50y

15

29.4

T stage at primary diagnosis

 T1

19

37.3

 T2

29

56.9

 T3

3

5.9

 T4

0

0

Primary N stage

 N0

21

41.2

 N1

20

39.2

 N2

5

9.8

 N3

5

9.8

Primary stage

 I

9

17.6

 II

30

58.8

 III

12

23.5

ER/PR status at primary diagnosis

 Negative

16

31.4

 Positive

33

64.7

Not available

2

3.9

HER-2/neu status at primary diagnosis

 Negative

38

74.5

 Positive a

6

11.8

 Not available

7

13.7

Prior surgery

 Modified radical mastectomy

42

82.4

 Radical mastectomy

9

17.6

Prior chemotherapy

 Yes

48

94.1

 No

3

5.9

Prior Hormone therapy

 TAM

27

52.9

 AI

5

9.8

 No

19

37.3

  1. a: Patients were considered to have HER-2/neu positive disease if primary tumor was positive for HER-2 by immunohistochemistry (+++) or by fluorescent in-situ hybridization